3D Bioprinting drug delivery (Additive Manufacturing)

This federal initiative aims to use today’s 3D printing technologies to improve supply chain resilience for American manufacturers. By accelerating the adoption of additive manufacturing (AM) across small and medium-sized companies, each of these AM-powered manufacturers will, in turn, contribute to building resilient supply chains for the U.S.-based domestic manufacturing ecosystem while also using 3D printing to improve their industrial competitiveness.